- Home
- IMNM vs LSB Comparison
IMNM vs LSB Comparison
Compare IMNM & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- LSB
- Stock Information
- Founded
- IMNM 2006
- LSB 2002
- Country
- IMNM United States
- LSB China
- Employees
- IMNM N/A
- LSB N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- LSB
- Sector
- IMNM Health Care
- LSB
- Exchange
- IMNM Nasdaq
- LSB NYSE
- Market Cap
- IMNM 747.7M
- LSB 49.8M
- IPO Year
- IMNM 2020
- LSB N/A
- Fundamental
- Price
- IMNM $10.97
- LSB $2.96
- Analyst Decision
- IMNM Strong Buy
- LSB
- Analyst Count
- IMNM 5
- LSB 0
- Target Price
- IMNM $28.60
- LSB N/A
- AVG Volume (30 Days)
- IMNM 911.8K
- LSB 22.5K
- Earning Date
- IMNM 11-13-2024
- LSB 01-21-2025
- Dividend Yield
- IMNM N/A
- LSB N/A
- EPS Growth
- IMNM N/A
- LSB N/A
- EPS
- IMNM N/A
- LSB N/A
- Revenue
- IMNM $10,129,000.00
- LSB $79,415,311.00
- Revenue This Year
- IMNM N/A
- LSB $39.33
- Revenue Next Year
- IMNM N/A
- LSB $75.61
- P/E Ratio
- IMNM N/A
- LSB N/A
- Revenue Growth
- IMNM N/A
- LSB N/A
- 52 Week Low
- IMNM $8.33
- LSB $1.88
- 52 Week High
- IMNM $30.96
- LSB $11.20
- Technical
- Relative Strength Index (RSI)
- IMNM 39.61
- LSB 55.32
- Support Level
- IMNM $10.76
- LSB $2.10
- Resistance Level
- IMNM $15.13
- LSB $2.77
- Average True Range (ATR)
- IMNM 0.98
- LSB 0.37
- MACD
- IMNM -0.29
- LSB 0.04
- Stochastic Oscillator
- IMNM 4.81
- LSB 61.40
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.